Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis.

Johann Sellner; I Greeve; O Findling; D Grandgirard; S L Leib; H P Mattle

doi:10.1111/j.1365-2249.2008.03630.x

Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis.

Johann Sellner^* (First author), I Greeve, O Findling, D Grandgirard, S L Leib, H P Mattle

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

6 Citations (Web of Science)

Original language	English
Pages (from-to)	280-284
Journal	CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume	152
Issue number	2
DOIs	https://doi.org/10.1111/j.1365-2249.2008.03630.x
Publication status	Published - 2008

Keywords

AUTOREACTIVE T-CELLS
FAS LIGAND
AUTOIMMUNE ENCEPHALOMYELITIS
IMMUNE-SYSTEM
MS PATIENTS
EXPRESSION
LYMPHOCYTES
MOLECULES
APOPTOSIS
THERAPY

Access to Document

10.1111/j.1365-2249.2008.03630.x

Cite this

Sellner, J., Greeve, I., Findling, O., Grandgirard, D., Leib, S. L., & Mattle, H. P. (2008). Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis. CLINICAL AND EXPERIMENTAL IMMUNOLOGY , 152(2), 280-284. https://doi.org/10.1111/j.1365-2249.2008.03630.x

Sellner, Johann ; Greeve, I ; Findling, O et al. / Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis. In: CLINICAL AND EXPERIMENTAL IMMUNOLOGY 2008 ; Vol. 152, No. 2. pp. 280-284.

@article{aaadb22674f248448e722a26303670a1,

title = "Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis.",

keywords = "AUTOREACTIVE T-CELLS, FAS LIGAND, AUTOIMMUNE ENCEPHALOMYELITIS, IMMUNE-SYSTEM, MS PATIENTS, EXPRESSION, LYMPHOCYTES, MOLECULES, APOPTOSIS, THERAPY",

author = "Johann Sellner and I Greeve and O Findling and D Grandgirard and Leib, {S L} and Mattle, {H P}",

note = "Sellner, J [1,2] ; Greeve, I [2] ; Findling, O [2] ; Grandgirard, D [3] ; Leib, SL [3] ; Mattle, HP [2] [1] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-81675 Munich, Germany [2] Univ Bern, Univ Hosp Bern, Inselspital, Dept Neurol, Bern, Switzerland [3] Univ Bern, Inst Infect Dis, Bern, Switzerland",

year = "2008",

doi = "10.1111/j.1365-2249.2008.03630.x",

language = "English",

volume = "152",

pages = "280--284",

journal = "CLINICAL AND EXPERIMENTAL IMMUNOLOGY ",

issn = "0009-9104",

number = "2",

}

Sellner, J, Greeve, I, Findling, O, Grandgirard, D, Leib, SL & Mattle, HP 2008, 'Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis.', CLINICAL AND EXPERIMENTAL IMMUNOLOGY , vol. 152, no. 2, pp. 280-284. https://doi.org/10.1111/j.1365-2249.2008.03630.x

Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis. / Sellner, Johann (First author); Greeve, I; Findling, O et al.
In: CLINICAL AND EXPERIMENTAL IMMUNOLOGY , Vol. 152, No. 2, 2008, p. 280-284.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis.

AU - Sellner, Johann

AU - Greeve, I

AU - Findling, O

AU - Grandgirard, D

AU - Leib, S L

AU - Mattle, H P

N1 - Sellner, J [1,2] ; Greeve, I [2] ; Findling, O [2] ; Grandgirard, D [3] ; Leib, SL [3] ; Mattle, HP [2] [1] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-81675 Munich, Germany [2] Univ Bern, Univ Hosp Bern, Inselspital, Dept Neurol, Bern, Switzerland [3] Univ Bern, Inst Infect Dis, Bern, Switzerland

PY - 2008

Y1 - 2008

KW - AUTOREACTIVE T-CELLS

KW - FAS LIGAND

KW - AUTOIMMUNE ENCEPHALOMYELITIS

KW - IMMUNE-SYSTEM

KW - MS PATIENTS

KW - EXPRESSION

KW - LYMPHOCYTES

KW - MOLECULES

KW - APOPTOSIS

KW - THERAPY

U2 - 10.1111/j.1365-2249.2008.03630.x

DO - 10.1111/j.1365-2249.2008.03630.x

M3 - Original Article

C2 - 18341614

SN - 0009-9104

VL - 152

SP - 280

EP - 284

JO - CLINICAL AND EXPERIMENTAL IMMUNOLOGY

JF - CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IS - 2

ER -

Sellner J, Greeve I, Findling O, Grandgirard D, Leib SL, Mattle HP. Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis. CLINICAL AND EXPERIMENTAL IMMUNOLOGY . 2008;152(2):280-284. doi: 10.1111/j.1365-2249.2008.03630.x